openPR Logo
Press release

Stomach Cancer Treatment Market to surpass USD 11.47 billion by 2030 owing to advances in the treatment modalities and an increasing incidence of gastrointestinal illness

02-06-2024 02:41 PM CET | Health & Medicine

Press release from: SNS Insider Pvt Ltd

Stomach Cancer Treatment Market

Stomach Cancer Treatment Market

Based on SNS Insider's research, Late-stage clinical studies for several novel medications, including pembrolizumab (Keytruda), lenvatinib (Lenvima), and TAK-659, are being conducted for the treatment of stomach cancer.

Market Size-

The SNS Insider report indicates that the Stomach Cancer Treatment Market was valued at USD 4.3 billion in 2022, and is expected to reach market size of USD 11.47 billion by 2030, with a compound annual growth rate (CAGR) of 13% expected over the forecast period from 2023 to 2030.

Market Report Scope -

The market research report on stomach cancer treatment is an essential tool for companies that are looking to remain in the competition of today's markets. In addition to growth trends, market size and key drivers and restraints, the report provides a comprehensive overview of the industry. This information will enable companies to make informed decisions and develop efficient strategies.

Get sample PDF of Stomach Cancer Treatment Market Report@

Key Players
-Novartis AG,
-Pfizer, Inc.,
-Mylan N.V.,
-F. Hoffmann La Roche Ltd,
-Eli Lilly And Company,
-Merck & Co., Inc.,
-Teva Pharmaceutical Industries Ltd.,
-Celltrion Healthcare Co., Ltd.,
-Samsung Bioepis,
-Bristol Myers Squibb
-Company and others.

Market Growth Factors-

Presence of Potential Pipeline Candidates to Boost the Market
Research and development of novel medicines to treat stomach cancer is being actively pursued by a number of pharmaceutical companies. Many potential candidates are at the end of their development, which is expected to have a huge impact on the market when they become available. Furthermore, different trastuzumab biosimilars are already on the market or in development.

Segmentation Analysis -

By Treatment Type
-Targeted Therapy
-Radiation Therapy and Surgery

By Disease Indication
-Gastric Cancer/Gastroesophageal Junction Cancer
-Gastrointestinal Stromal Tumors
-Route of Administration

By Drug Class
-PD-1/PD-L1 Inhibitors
-HER2 Antagonists
-VEGFR2 Antagonists

By Distribution Channel
-Hospital Pharmacies
-Specialty & Retail Pharmacies

Based on treatment type, due to a high prescription rate, the chemotherapy segment accounted for more than 40.6% of total stomach cancer therapy revenues in 2022. First-line therapy for patients diagnosed in early stages is generally surgery with adjuvant chemotherapy or neoadjuvant chemotherapy. An article suggests that around 65% of patients with advanced cancers, 85% with lymph node metastases, and 40% with metastatic disease undergo surgical procedures. Chemotherapy can be given either as neoadjuvant chemotherapy or adjuvant chemotherapy to shrink the tumor or kill the cancerous cells. The market is divided according to the type of treatment, namely chemotherapy, immunotherapies and targeting therapy.

In 2022, based on Distribution Channel the specialty and retail pharmacies accounted for more than 65.3% of revenue in the market for treating stomach cancer. Due to the need to store and distribute the medicines under specific conditions, most of the medicines used for the treatment of gastric cancer are distributed through specialised pharmacies. For example, Blueprint Medicines recently selected PANTHERx Rare Pharmaceutics and Biologics from McKesson to distribute its GIST treatment AYVAKIT in June 2021. The market is divided into hospital pharmacies, specialty and retail pharmacies as well as others on account of the distribution channels.

Need Customized Report as per Your Business Requirement Ask Here @

Key Regional Development -

In 2022, the Asia Pacific region accounted for more than 55.6% of total revenue in the stomach cancer treatment market. This is mainly due to the higher prevalence of gastric cancer in this region. For instance, there were around 138,000 new cases in Japan in 2020 and around 479,000 in China. However, chemotherapy remains the preferred treatment option for many countries such as China; nevertheless, there will be an increased regional growth over the forecast period due to a robust product pipeline and anticipated approval of these products.

The growing investments in developing advanced treatments options and an increasing target patient population, Europe is expected to experience considerable growth over the forecast period. For example, Opdivo was approved by the European Commission for the treatment of gastrointestinal junction cancer in October 2021.

Key Takeaway from Stomach Cancer Treatment Market Study-

Market growth is expected to be driven by increasing incidences of stomach cancer as well as increased use of targeting immunotherapies.

The surgical sector is expected to dominate the market throughout the forecast period, given the high incidence of stomach cancer and the increasing use of surgical treatments.

Roche, AstraZeneca, Novartis, Pfizer, Merck and others are major players in the market for treatment of stomach cancer.

Recent Development Related to Stomach Cancer Treatment Market-

In April 2021, Bristol Myers Squibb received U.S FDA approval for Opdivo (nivolumab) as the first immunotherapy for first-line treatment of gastric cancer.

In May 2021, In the treatment of gastric cancer, Bold Therapeutics has been granted orphan drug designation for BOLD 100. BOLD-100 is a first of its kind, a small molecule therapeutics based on ruthenium.

Buy Stomach Cancer Treatment Market Report@

Table of Contents


2.Research Methodology

3.Market Dynamics

4.Impact Analysis

4.1COVID-19 Impact Analysis

4.2.Impact of Ukraine- Russia war

4.3.Impact of Ongoing Recession on Major Economies

5.Value Chain Analysis

6.Porter's 5 Forces Model

7.PEST Analysis

8.Stomach Cancer Treatment Market Segmentation, By Treatment Type

9.Stomach Cancer Treatment Market Segmentation, By Disease Indication

10.Stomach Cancer Treatment Market, By Drug Class

11.Stomach Cancer Treatment Market, By Distribution Channel

12.Regional Analysis

13 Company profile

14.Competitive Landscape

15.USE Cases and Best Practices



Access Complete Report Details with Toc and Graphs@

Contact Us:
Akash Anand - Head of Business Development & Strategy
Phone: +1-415-230-0044 (US) | +91-7798602273 (IND)

About Us:
SNS Insider is one of the leading market research and consulting agencies that dominates the market research industry globally. Our company's aim is to give clients the knowledge they require in order to function in changing circumstances. In order to give you current, accurate market data, consumer insights, and opinions so that you can make decisions with confidence, we employ a variety of techniques, including surveys, video talks, and focus groups around the world.

This release was published on openPR.

Permanent link to this press release:

Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Stomach Cancer Treatment Market to surpass USD 11.47 billion by 2030 owing to advances in the treatment modalities and an increasing incidence of gastrointestinal illness here

News-ID: 3374499 • Views:

More Releases from SNS Insider Pvt Ltd

Automotive Digital Cockpit Market Size is Predicted to Grow USD 29.14 billion by 2031 Due to Rise of Mobile Services
Automotive Digital Cockpit Market Size is Predicted to Grow USD 29.14 billion by …
Automotive Digital Cockpit Market Overview: The SNS Insider report indicates that the Automotive Digital Cockpit Market was valued at  USD 15.98 billion in 2023, and it is projected to achieve a market size of USD 29.14 Billion by 2031 with a compound annual growth rate CAGR of 7.87% expected over the forecast period from 2023 to 2030. The automotive digital cockpit market indeed continues to witness significant growth, driven by advancements in technology and
Semi-Autonomous Vehicle Market Hits $113.76 Million by 2030
Semi-Autonomous Vehicle Market Hits $113.76 Million by 2030
The SNS Insider report indicates that the 𝐒𝐞𝐦𝐢-𝐀𝐮𝐭𝐨𝐧𝐨𝐦𝐨𝐮𝐬 𝐕𝐞𝐡𝐢𝐜𝐥𝐞 𝐌𝐚𝐫𝐤𝐞𝐭 was valued at US$ 24.27 million in 2022, and it is projected to achieve a market size of 𝐔𝐒$ 𝟏𝟏𝟑.𝟕𝟔 𝐦𝐢𝐥𝐥𝐢𝐨𝐧 𝐛𝐲 𝟐𝟎𝟑𝟎, with a compound annual growth rate (CAGR) of 21.3% expected over the forecast period from 2023 to 2030. 𝐀 𝐂𝐨𝐦𝐩𝐫𝐞𝐡𝐞𝐧𝐬𝐢𝐯𝐞 𝐌𝐚𝐫𝐤𝐞𝐭 𝐑𝐞𝐩𝐨𝐫𝐭 𝐒𝐜𝐨𝐩𝐞: As technology continues to advance, the capabilities of autonomous and semi-autonomous vehicles are expected to improve
Heart Failure POC & LOC Devices Market Worth US$ 286.42 Million by 2030
Heart Failure POC & LOC Devices Market Worth US$ 286.42 Million by 2030
Heart Failure POC & LOC Devices Market Report Scope & Overview According to SNS Insider's analysis, the allure of miniaturization combined with its potential to revolutionize disease diagnosis through cost-efficiency, simplicity in operation, and analytical capabilities is a standout feature of lab-on-chip (LOC) technology. Driving the market forward will be the dynamic landscape of research and development endeavors focused on pioneering novel LOC tests tailored for the detection of cardiovascular disease
Regenerative Medicine Market Size, Share, Segmentation, Opportunities & Industry forecast by 2030
Regenerative Medicine Market Size, Share, Segmentation, Opportunities & Industry …
Regenerative Medicine Market Sizing According to the SNS Insider Report, the market size of Regenerative Medicine was assessed at US$ 25.65 Bn in 2022, with projections pointing towards a growth to US$ 90.13 Bn by 2030. This signifies a compound annual growth rate (CAGR) of 17.01% during the forecast period from 2023 to 2030 Regenerative Medicine Market Report Scope The Regenerative Medicine Market Report is comprehensive analysis of the global market for

All 5 Releases

More Releases for Cancer

Cancer Therapeutics Market New Business Opportunities to Hit $180.19 billion by …
Surge in geriatric population and rise in the number of collaborations & partnerships to facilitate drug development are the key drivers of the global cancer therapeutics market. In addition, heavy inflow of investment in R&D activities has enhanced the development of cancer therapeutics. Furthermore, favorable government regulations for cancer therapeutics and surge in cancer prevalence boost the market. The high demand for personalized medicine along with high potential of emerging
Global Cancer Diagnostics Market Size, Trends & Growth Opportunity By Applicatio …
Cancer diagnostics is a process of detecting various proteins, biomarkers and certain symptoms that result in the detection of presence of cancerous tumour in patients. Detection of certain proteins and biomarkers which are prevalent in cancer disorder thereby results in diagnosis process. Cancer diagnostics includes usage of certain technology and devices for detection purpose. Increase in incidence of target diseases like cancer is key driving factor which is expected to boost
Oncology Nutrition Market led to an unprecedented rise by 2025 : liver cancer, p …
Global Oncology Nutrition Market: Overview Cancer diagnosis creates myriad questions about diet and nutrition. Those pertain to if the food will make a patient feel sick to what should be ingested to fight cancer. This has spawned the oncology nutrition market which has been rising steadily due to the increasing cases of different types of cancer worldwide. During cancer treatment one needs to eat right in order to build up strength
Cancer Immunotherapy Market 2018 To 2025 - SWOT Analysis By Global Industry Reve …
The Cancer Immunotherapy Market research report provided by Crystal Market Research (CMR) is the most detailed study about Cancer Immunotherapy Market that is estimated to grow at a tremendous rate over the forecast period 2018-2025. This report contains precise and updated insights in respect with the leading market players and prevailing regions of the business. Cancer Immunotherapy Market By Product and Cancer Type - Global Industry Analysis And Forecast To 2025:
Oncology Nutrition Market by Cancer Type Breast Cancer, Liver Cancer, Lung Cance …
Lunch of new products for nutrition of oncology patients is expected to drive the oncology nutrition market growth. For instance, in 2016, Hormel Food Corporation, a U.S-based meat food products company, launched a line of packaged ready-to-eat meals for cancer patients, which are called as Hormel Vital Cuisine. These meals consist of carbohydrates, proteins, and fats to help patients fight loss of muscle mass and energy during cancer treatment. Thus launch
Cancer Diagnostics Global Market: By Application - Breast Cancer, Lung Cancer, C …
Researchmoz added Most up-to-date research on "Cancer Diagnostics Global Market: By Application - Breast Cancer, Lung Cancer, Colorectal Cancer, Melanoma & Other Cancers" to its huge collection of research reports. This report studies Cancer Diagnostics in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022. This report focuses on top